jonzobot - On the plus side, now that the world is opening up, it stands to reason that the covid-related interference/delay in clinical trials (like BOM2) will gradually go away.

Maybe not - least we forget the study in Australia with cultured heart cells.  Seems even those "cured" from C19,  their cured blood caused issues with heath cells.  Then came Apabetalone, in the lab, cells returned to original condition.

We do not know the long term effects of C19.  C19 is different and mutating.  Just because we can go back to being "normal" does not mean we are safe.

Apabetalone will be needed world wide.  Count on it.  The single inhibitor of ACE2 and BRD4, both combined, causes many other health issues.  Keep the faith.  sidebar.